Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,647,998
-$13,332,959 QoQ
Shares Held
2,045,490
-31.4% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. REPL ranks #137 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,647,998 | 2,045,490 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,980,957 | 2,981,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,702,921 | 1,361,079 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,638,520 | 391,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,932,867 | 403,371 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,205,585 | 347,282 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,865,475 | 626,412 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,724,692 | 747,188 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,340,532 | 286,479 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,962,007 | 825,861 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,707,165 | 1,268,683 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,864,868 | 1,544,568 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,369,997 | 1,153,454 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $37,547,804 | 1,380,434 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,871,843 | 1,092,753 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $19,056,870 | 1,090,210 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,352,492 | 1,080,830 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,566,624 | 1,054,119 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,244,086 | 1,054,119 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $40,499,251 | 1,054,119 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $41,624,335 | 1,364,285 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $100,197,808 | 2,626,417 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $21,148,911 | 918,719 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $28,021,331 | 1,127,619 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $8,870,906 | 889,760 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||